Th e GINECO trial explored the combination of trastuzumab with paclitaxel and carboplatin in patients with resistant AOC (< 6 months) and HER2 gene amplification. Patients and Methods: A total of ...

HER2-overexpressing breast cancer Trastuzumab, in combination with an anthracycline- and taxane-containing chemotherapy regimen, has become the universally-accepted standard of care for high-risk ...

Medically reviewed by Lindsay Cook, PharmD If you have HER2-positive breast cancer, your options for treatment will depend on ...

After chemotherapy failure, if the cancer is also resistant to endocrine therapy, patients face a double obstacle: few ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Herceptin SC? Herceptin SC contains the active ...

A combination of tucatinib, trastuzumab and chemotherapy drug capecitabine is already approved for patients who have metastatic breast cancer with high levels of HER2 expression (known as HER2 ...

It’s often used alone or with other cancer treatments, including chemotherapy. Trastuzumab (Herceptin) and pertuzumab (Perjeta) are the two most common monoclonal antibodies used to treat human ...

Evidence shows that some drugs - such as herceptin - can keep breast cancer at bay and prolong lives for up to six months. And other drugs including Glivec, used to treat chronic leukaemia, can ...

In the almost 30-years since the protests at the Genentech headquarters, HER2+ breast cancer treatments that include Herceptin® - such as chemotherapy with the addition of Herceptin® or ...

Drugs used with chemotherapy Herceptin: Women with aggressive forms of breast cancer are being given new hope of survival with this drug. Although the drug is licensed in Britain, the drug has yet ...